Introduction
Tamoxifen is largely used in the first-line treatment of estrogen receptor (ER)-positive breast cancer (Love, 1989) . By binding to ER, tamoxifen antagonizes estrogen activity by recruiting co-repressors of transcription to ER target genes (Smith et al., 1997) . However, in vitro studies have shown that at micromolar concentrations tamoxifen exerts anticancer activity by inducing apoptosis of tumor cells regardless of ER expression (Mandlekar and Kong, 2001) . Apoptotic cell death is characterized by the activation of a cascade of intracellular cysteine proteases culminating with the activation of downstream caspases 3, 6 and 7. These effector-caspases execute the terminal phases of apoptosis by cleaving a variety of substrates including those triggering DNA fragmentation (Porter and Janicke, 1999) . Several transduction pathways have been shown to mediate tamoxifen-induced apoptosis, including activation of PKC, intracellular Ca 2 þ and TGF-b (Mandlekar and Kong, 2001) . It has been shown that tamoxifen-dependent elevation of intracellular Ca 2 þ triggers apoptosis of human hepatoblastoma HepG2 cancer cells through the accumulation of reactive oxygen species (ROS) obtained by not-phagocytic activation of NADPH oxidase (Lee et al., 2000) . ROS-induced apoptosis requires the participation of further cell death signaling pathways, including the c-Jun N-terminal kinase (JNK) family of stress-responsive MAPKs (Shen et al., 1996) . In particular, it has been shown that prevention of ROS accumulation by antioxidants inhibits both JNK activation and apoptosis in tamoxifen-treated cancer cells (Mandlekar et al., 2000; Mabuchi et al., 2004) . These studies pointed to ROSactivated JNK as a crucial effector of tamoxifen-induced apoptosis. However, downstream targets of the JNK pathway involved in tamoxifen-induced apoptosis have not been identified.
It has been largely shown that c-Jun represents the principal transcription factor mediating gene regulation by JNK (Davis, 2000; Dunn et al., 2002) . JNK induces c-Jun transactivation by phosphorylating the c-Jun N-terminal domain at serines 63/73 and threonines 91/93 (Bannister et al., 1995; Papavassiliou et al., 1995; Morton et al., 2003; Weiss et al., 2003; Nateri et al., 2005; Vinciguerra et al., 2008) . By forming stable homodimeric or heterodimeric complexes with Fos or ATF family members, c-Jun constitutes the inducible activator protein-1 (AP-1) transcription factor. Both genetic and biochemical studies indicate that AP-1 is involved in different cellular processes including proliferation, differentiation and apoptosis (Shaulian and Karin, 2001; Eferl and Wagner, 2003; Hess et al., 2004) . However, several studies have shown that the functional output of AP-1 depends on the levels of expression and activation of the individual AP-1 members that make up the AP-1 dimers, as well as the type of stimulus and the intracellular environment (Eferl and Wagner, 2003; Hess et al., 2004) . It has been widely shown that the JNKc-Jun pathway contributes to stress-induced apoptosis in different cell types, such as neurons, fibroblasts or DNA-damaged cancer cells (Behrens et al., 1999; Dunn et al., 2002; Raivich, 2008) . In contrast, c-Jun phosphorylation at serine 63 and 73 (S63/S73) is also important for cell cycle progression or intestinal tumor progression (Eferl and Wagner, 2003; Wada et al., 2004; Nateri et al., 2005) , suggesting that additional phosphorylation of c-Jun at threonine 91 and 93 (T91/T93) might be critical for c-Jun pro-apoptotic functions. In line with this suggestion, we have recently shown that phosphorylation of c-Jun at all four JNK sites is crucial for c-Jun pro-apoptotic function in response to DNA damage (Vinciguerra et al., 2008) . Furthermore, JNKspecific phosphorylation of c-Jun at T91/T93, but not at S63/S73, requires a priming phosphorylation at T95 by a yet to be identified stress-induced kinase (Vinciguerra et al., 2008) . These observations suggest that depending on the type of stimulus c-Jun may or may not be phosphorylated at all four terminal sites by JNK and correspondingly it may result in different cellular consequences. Therefore, the analysis of N-terminal phosphorylation of c-Jun at both S63/73 and T91/T93 is essential for associating c-Jun activation to either prosurvival or pro-apoptotic pathways. To date, c-Jun phosphorylation in response to tamoxifen has been analysed only in tamoxifen-resistant MCF-7-derived xenografts and limited to the S63 site (Schiff et al., 2000) .
c-Fos, the main heterodimeric partner of c-Jun, has also been shown to be involved in both proliferative and apoptotic pathways (Hess et al., 2004) . c-Fos expression can be induced by a variety of stimuli, each acting on one or more multiple cis-elements contained within the promoter of c-Fos (Treisman, 1995) . In this regard, it has been reported that the serum-responsive element recruits ERK-activated Elk-1 as well as the serumresponsive factor accessory proteins 1 and 2 to the c-Fos promoter sequence (Price et al., 1995) . Accordingly, in our previous studies both estrogen and 4-hydroxytamoxifen (OHT)-induced c-Fos expression by ERKdependent activation of Elk-1 (Maggiolini et al., 2004; Vivacqua et al., 2006a, b) . These studies, as well as other reports (Prossnitz and Maggiolini, 2009) , indicate that the aforementioned stimulations may occur through the G protein-coupled receptor (GPR)30 in conjunction (Mandlekar et al., 2000) . We used the ER-negative breast cancerderived cell line SkBr3 as a model system to analyse the role of JNK-activated c-Jun in the OHT-dependent apoptosis. First, we examined whether micromolar concentrations of OHT, which were earlier reported to be cytotoxic in SkBr3 cells (Basu et al., 2004) , could induce hallmarks of apoptotic cell death such as DNA fragmentation and caspase 3/7 activation. As shown by flow cytometric analysis, DNA fragmentation was induced by 10 mM OHT and was further increased by 25 mM OHT, whereas neither concentration had any influence on cell cycle phases (Figures 1a and b) . The effect of 10 mM OHT on DNA fragmentation was further confirmed by TdT-mediated dUTP nick end labeling (TUNEL) staining and cell viability assay (Figures 1c  and d) . Furthermore, OHT-induced caspase 3/7 activities ( Figure 1e ), suggesting that DNA fragmentation results from apoptosis. Next, we analysed whether JNKactivated c-Jun precedes OHT-dependent apoptosis in SkBr3 cells. To this end, we examined the ability of OHT to induce c-Jun N-terminal phosphorylation at either S73, a hallmark of c-Jun activation by JNK (Dunn et al., 2002) , or at T91/T93, which are stringently correlated with c-Jun pro-apoptotic activity (Vinciguerra et al., 2008) . Phosphorylation of both S73 and T91/ T93 sites was induced on a 2 h exposure to OHT and no longer detected in presence of the JNK-specific inhibitor SP (Figures 2a and b) , indicating that JNK-specific activation of c-Jun precedes OHT-induced apoptosis. In contrast, neither the EGFR inhibitor AG, nor the MEK/ERK inhibitor PD and the ER pure antiestrogen ICI prevented c-Jun phosphorylation by OHT. As OHT has been shown to induce JNK activation through generation of oxidative stress (Lee et al., 2000; Mandlekar and Kong, 2001; Mabuchi et al., 2004) , we next analysed the effect of the antioxidant N-acetyl-L-cysteine (NAC) on the JNK/c-Jun pathway. As shown in Figure 2c , both activation of JNK and c-Jun phosphorylation at T91/T93 sites were prevented by NAC treatment. In line with previous studies, the exposure to NAC prevented also DNA fragmentation by OHT ( Figure 2d ). These results indicate that c-Jun pro-apoptotic phosphorylation by OHT is triggered by oxidative stress and is associated with DNA fragmentation.
OHT induces c-Fos expression in SkBr3 cells
In addition to c-Jun activation, we analysed whether OHT induces c-Fos expression in SkBr3 cells, at both messenger RNA and protein levels. As shown by either reverse transcription-PCR analysis or western blots, the expression of c-Fos was rapidly induced by OHT (Figures 3a and b ). In agreement with our previous studies performed in different cancer cell types (Vivacqua et al., 2006a, b) , c-Fos induction by OHT was sensitive to AG and PD but not to SP or ICI ( Figure 3b ). It is noteworthy that the effect of OHT on c-Fos expression was also abrogated silencing GPR30 expression ( Figures  3c and d) , which we have shown earlier to mediate c-Fos 
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A Madeo et al induction by estrogens through ERK activation (Maggiolini et al., 2004; Vivacqua et al., 2006a, b) . Accordingly, OHT-dependent activation of ERK was sensitive to either PD or abrogation of GPR30 expression (Figures 3e and f) . In contrast, NAC treatment had no effect on either ERK activation or c-Fos expression, indicating that OHT induces the ERK/c-Fos pathway independently from its ability to trigger oxidative stress (Supplementary Figure 1) . Taken together, these results suggest that OHT induces c-Fos expression through the GPR30-EGFR-ERK transduction pathway in SkBr3 cells.
OHT transactivates an AP-1-responsive promoter Next, we evaluated whether OHT-dependent induction of c-Jun N-terminal phosphorylation and c-Fos expression lead to AP-1 transactivation.
To this end, we tested the ability of OHT to activate the AP-1-responsive collagenase promoter fused to a luciferase reporter gene (AP-1-luc). As shown in Figure 4a , OHT-induced AP-1-luc transactivation, which was sensitive to either SP, AG or PD, but not to ICI. Furthermore, only AG and PD inhibited the transactivation of the c-Fos promoter by OHT (Figure 4b ), hence corroborating the specific role exerted by ERK activation in OHT-induced c-Fos expression. Overall, these findings suggest that both JNK-specific activation of c-Jun and ERK-dependent induction of c-Fos expression contribute to AP-1 activation by OHT.
Abrogation of either c-Jun phosphorylation or AP-1 transactivation protects SkBr3 cells from OHT-induced apoptosis
We then analysed the specific involvement of c-Jun/ c-Fos AP-1 complex in OHT-induced apoptosis. To this aim, we performed TUNEL assays in OHT-treated cells ectopically expressing a truncated form of c-Fos (A-Fos), which was shown earlier to efficiently knockdown c-Jun/c-Fos AP-1 heterodimers (Olive et al., 1997) . (Papavassiliou et al., 1995; Watson et al., 1998; Dunn et al., 2002) . Expression of HA-tagged c-Jun-PanAla protected SkBr3 cells from OHT-induced apoptosis, as only 6% of HA-positive cells were also positive for TUNEL staining, while 58% of HA-negative cells were TUNEL positive (Figures 6i-p) . In contrast, ectopic expression of c-Jun-wt had no effect on DNA fragmentation (Figures 6a-h ), indicating the abrogation of JNK-specific phosphorylation of c-Jun is essential to protect SkBr3 cells from OHT-induced apoptosis. Furthermore, a c-Jun mutant that cannot be specifically phosphorylated at the T91/T93 JNK sites (Vinciguerra et al., 2008) was as efficient as c-Jun-PanAla to protect SkBr3 cells from OHT-dependent apoptosis ( Figures  6q-x) , showing that c-Jun N-terminal phosphorylation at T91/T93 site has a pivotal role in OHT-dependent apoptosis.
OHT OHT is triggered by oxidative stress, we asked whether the resistance of LNCaP cells to OHT-induced apoptosis correlated with a deficiency in ROS production and consequential lack of activation of the JNK/c-Jun pathway. To this end, we examined the ability of OHT to generate ROS in either SkBr3 or LNCaP cells by DCFH fluorescence (Shen et al., 1996) . As show in c-Jun mediates 4-hydroxytamoxifen-induced apoptosis A Madeo et al type of stimulus as well as on the heterodimeric partner forming the AP-1 transcription factor (Hess et al., 2004; Raivich and Behrens, 2006) . In this study, we analysed whether JNK-dependent activation of c-Jun has a role in OHT-induced cell death of ER-negative SkBr3 breast cancer cells. To this end, we first established by fluorescence-activated cell sorting analyses the range of micromolar OHT concentrations required to induce DNA fragmentation (Figure 1 ), as also confirmed by TUNEL and cell viability assays (Figure 1) . Importantly, we found that OHT triggers caspase 3/7 activity (Figure 1 ), suggesting that DNA fragmentation by OHT is a secondary consequence of apoptosis rather than necrosis. Moreover, OHT had no effects on cell cycle progression (Figure 1 ), excluding the possibility that OHT-dependent cytotoxicity was due to cell growth arrest. Next, we analysed the ability of OHT to induce JNKdependent phosphorylation of c-Jun at the S73 site, which is considered a hallmark of c-Jun activation in several paradigms of stress signals (Dunn et al., 2002) . We detected both JNK activation (Figure 2 ) and c-Jun phosphorylation at S73 on a 2 h exposure to OHT (Figure 2) . Remarkably, OHT also induced phosphorylation of c-Jun at T91/T93 sites (Figure 2) , which was shown to be crucial for c-Jun-mediated cell death in response to either ultraviolet or etoposide (Vinciguerra et al., 2008) . Moreover, both S73 and T91/T93 phosphorylations by OHT were specifically sensitive to SP, indicating that JNK-specific activation of c-Jun precedes apoptosis in SkBr3 cells. Interestingly, OHT-induced c-Jun N-terminal phosphorylation without alteration of c-Jun expression (Figures 2 and 7) , suggesting that activation of c-Jun by OHT is limited to pre-existing c-Jun proteins. Accordingly, our (unpublished observations) and other studies (Nephew et al., 1993) , have indicate that c-Jun expression is not regulated by OHT treatment. Importantly, DNA degradation as well as JNK activation and N-terminal phosphorylation of c-Jun, were abrogated by antioxidant treatments (Figure 2) . These results suggest that generation of oxidative stress, presumably by NADPH activation (Lee et al., 2000) , could be the initial OHT-dependent signal leading to activation of the JNK/c-Jun pathway and thereafter to apoptosis.
We then asked whether c-Jun activation by OHT was coupled to induction of c-Fos expression. Transactivation assays of the c-Fos promoter (Figure 4 ) combined with the analysis of steady-state levels of both c-Fos protein and messenger RNA (Figure 3 ) indicated that OHT leads to transcriptional induction of c-Fos expression. Interestingly, both the transactivation of the c-Fos promoter and the induction of c-Fos protein levels were sensitive to AG or PD, but not to SP or ICI, indicating that OHT induces c-Fos expression independently of its ability to induce JNK activity but rather in an EGFR/ERK-mediated manner. Accordingly, OHTdependent activation of ERK was abrogated by PD but not by SP (Figure 3 ), confirming that JNK activity is not required for the signaling pathway upstream c-Fos expression. Moreover, both c-Fos expression (Figure 3 ) and ERK activation (Figure 3 ) by OHT were sensitive to GPR30 silencing, in accordance with our previous studies performed in different cancer cells (Maggiolini et al., 2004; Vivacqua et al., 2006a, b; Albanito et al., 2007) . It is noteworthy that the ERK/c-Fos pathway was not altered by antioxidant treatment (Supplementary Figure 1) , thus corroborating the fact that OHT initiates two distinct signaling pathways converging to activation of the c-Jun/c-Fos AP-1 complex.
Induction of c-Fos expression coupled to c-Jun N-terminal phosphorylation is the most frequent encountered paradigm of AP-1 activation in mammalian cells. Indeed, we found that OHT-induced AP-1 transactivation in an ERK and JNK-dependent manner (Figure 4) , suggesting that the heterodimeric c-Jun/ c-Fos AP-1 complex functions in OHT-induced apoptosis of cancer cells. Alternatively, because of the crucial role of AP-1 in a variety of cellular events, activation of c-Jun/c-Fos AP-1 complex by OHT may reflect a prosurvival response. To evaluate the specific involvement of c-Jun/c-Fos in OHT-dependent apoptosis, we abrogated c-Jun/c-Fos AP-1 activity in SkBr3 cells by two independent experimental approaches: (i) ectopic expression of A-Fos, a truncated form of c-Fos that has been shown to specifically knock-down c-Jun/c-Fos AP-1 heterodimers (Olive et al., 1997) ; and (ii) ectopic expression of c-Jun-PanAla, a c-Jun mutant bearing alanine substitution of all four JNK phosphorylation sites S63/S73 and T91/T93, which has been shown to act as a c-Jun dominant negative in several cell lines (Papavassiliou et al., 1995; Watson et al., 1998; Dunn et al., 2002) . A-Fos overexpression protected cells from OHTinduced apoptosis, indicating that c-Jun/c-Fos hetero- , or p-c-Jun S73 , respectively. Expression levels of JNK and c-Jun proteins were detected using the non-phospho-specic antibodies, as indicated.
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A Madeo et al dimers are directly involved in apoptosis. This finding was further corroborated by the evidence that AP-1 transactivation by OHT was dependent on both ERK and JNK activity (Figure 4) . Similarly, overexpression of c-Jun-PanAla resulted in the protection of SkBr3 cells from OHT-induced apoptosis ( Figure 6 ). As Jun-wt had c-Jun mediates 4-hydroxytamoxifen-induced apoptosis A Madeo et al no effect on DNA degradation (Figure 6 ), the protective effect of c-Jun-PanAla presumably results from its ability to act as dominant-negative, indicating that JNK-activated c-Jun is necessary to trigger OHTinduced apoptosis. Moreover, a c-Jun mutant that specifically cannot be phosphorylated at the T91/T93 JNK sites was as efficient as c-Jun-PanAla in protecting SkBr3 cells from OHT-dependent apoptosis, suggesting that phosphorylation of c-Jun at S63/S73 is not sufficient to trigger c-Jun-dependent apoptosis. It is noteworthy that ectopic expression of c-Jun could not significantly increase the number of TUNEL-positive cells (Figure 6 ), indicating that activation of pre-existing c-Jun proteins by OHT is sufficient to trigger apoptosis. Our data show that OHT induces both ERK/c-Fos and JNK/c-Jun pathways in various OHT-sensitive cancer cells (Figure 7) , pointing to c-Jun/c-Fos AP-1 activation as a general mechanism mediating OHTdependent apoptosis, rather than a peculiar response of SkBr3 cells. Accordingly, OHT-induced caspase 3/7 activity and DNA degradation in all cancer cell types used, except in OHT-resistant LNCaP prostate cancer cells (Figure 7) . It is noteworthy that OHT failed to induce both c-Fos expression and c-Jun N-terminal phosphorylation in LNCaP cells (Figure 7) , validating that the upregulation of c-Jun/c-Fos AP-1 by cytotoxic concentrations of OHT is linked to caspase 3/7 activation and in turn to cell death.
How c-Jun/AP-1 drives cell death in OHT-treated cancer cells remains to be elucidated. The JNK/c-Jun pathway has been shown to regulate the release of cytochrome c from mitochondria (Whitfield et al., 2001) . In line with this observation, active c-Jun is required for the expression of genes that increase mitochondrial outer membrane permeability, such as Bim and Dp5, which are members of the proapoptotic BH3-only subfamily of Bcl-2 proteins (Ham et al., 2005) . A crucial role of mitochondria has been also shown in OHTinduced apoptosis, as it can elicit the release of mitochondrial cytochrome c altering the expression of Bcl-2 proteins (Mandlekar and Kong, 2001; Kallio et al., 2005; Lagadec et al., 2008) . Therefore, downregulation of the antiapoptotic Bcl-2 protein together with upregulation of one or more proapototic Bcl-2 proteins may constitute a critical mechanism promoting mitochondrial dysfunction by OHT. Presumably, the JNK/c-Jun pathway may contribute to this intrinsic proapoptotic mechanism by upregulating one or more proapototic BH3-only proteins. In contrast, as c-Jun/ AP-1 controls tumor necrosis factor-a expression Pope et al., 2000) , we cannot exclude a putative role of c-Jun in a cross talk between the death receptor and mitochondrial pathways.
Our previous studies have shown that one micromolar OHT induces cell proliferation in thyroid and endometrial cancer cells by activating the EGFR/GPR30/ERK pathway and in turn c-Fos expression (Vivacqua et al., 2006a (Vivacqua et al., , 2006b , whereas it has no effects on the JNK/ c-Jun pathway (Madeo A, unpublished observations). These observations together with this study lead to the hypothesis that the functional output of c-Fos induction by OHT may depend on whether or not there is a concomitant c-Jun activation by JNK signaling. As antioxidant pathways are often enhanced in cancer cells (Friesen et al., 2004; Young et al., 2004; Recktenwald et al., 2008; Ballatori et al., 2009) , the resistance of certain cancer cells to tamoxifen may depend on their ability to prevent ROS accumulation and in turn JNKspecific activation of c-Jun. In line with this hypothesis we found that OHT induced ROS accumulation in SkBr3 cells but not in LNCaP cells (Figure 8) . Hence, pharmacological boosts of c-Jun N-terminal phosphorylation may be useful to sensitize cancer cells to OHT-mediated cell death.
Materials and methods

Cell culture
SkBr3 breast cancer cells were maintained in RPMI 1640 without phenol red supplemented with 10% fetal bovine serum (FBS). MCF-7 and BT20 breast cancer cells were cultured respectively in DMEM-F12 or MEM with phenol red supplemented with 10% FBS. HePG2 hepatocarcinoma cells, LoVo colorectal adenocarcinoma cells and LNCaP prostate cancer cells were maintained in RPMI 1640 with phenol red and supplemented with 10% FBS. SCLC-R1 lung cancer cells were cultured in RPMI 1640 with phenol red, one Â nonessential amino acids, one Â sodium pyruvate and 10% FBS. Cells were switched to medium without serum the day before experiments for immunoblots and reverse transcription-PCR. All compounds were solubilized in dimethyl sulfoxide (DMSO), except for OHT that was dissolved in ethanol (EtOH) and N-acetyl-L-cysteine (NAC) that was dissolved in H 2 O. For TUNEL assays and immunofluorescent detection experiments propidium iodide and DAPI were purchased from Sigma-Aldrich Corporation.
Plasmids
The short hairpin RNA construct to knock-down the expression of GPR30 and the unrelated short hairpin RNA control construct have been described earlier (Albanito et al., 2008) . The expression vector encoding for c-Fos protein was described earlier (Papavassiliou et al., 1992) . The plasmid A-Fos was a kind gift from Dr C Vinson (NIH, Bethesda, MD, USA). The expression vector encoding for c-Jun protein (HA-c-Jun) and a non-functional c-Jun protein mutated in phosphorylation sites (HA-c-Jun-PanAla and HA-c-Jun-Ala 91/93) have been described earlier (Musti et al., 1997) . The luciferase reporter plasmid for c-fos encoding a À2.2 kb 5 0 upstream fragment of human c-fos was a kind gift from K Nose, Showa University, Tokyo, Japan. The luciferase reporter plasmid for 4 Â AP-1-responsive collagen promoter was a kind gift from H van Dam (Department of Molecular Cell Biology, Leiden University, Leiden, The Netherlands).
Flow cytometry
Evaluation of cell-cycle distribution and subG1 peaks by flow cytometric analysis was performed as follows: floating and adherent cells were collected by trypsin/ethylene-diaminetetraacetic acid, washed in cold phosphate-buffered saline (PBS) and fixed with 70% cold ethanol for 1 h. After removing ethanol by PBS washes, cells were incubated in 10 mg/ml deoxyribonuclease-free ribonuclease A for 30 min at 37 1C and then in 50 mg/ml Propidium iodide for 20 min at 4 1C. Cells were then analysed by flow cytometry using a FacScan Flow Cytometer Apparatus (488 nm argon laser-CyAn ADP, Dako, Milan, Italy). Acquisition and analysis was performed using Summit software. The analysis on dot-plot of FL2 area versus FL2 width gating was performed to exclude doublets from G2M region. For each sample, 30 000 events were analysed.
Transfection and luciferase assay SkBr3 cells (1 Â 10 5 ) were plated in 24-well dishes with 500 ml of regular growth medium per well the day before transfection. The medium was replaced with that lacking serum on the day of transfection performed using Fugene 6 reagent, as recommended by the manufacturer (Roche Diagnostics, Milan, Italy) with a mixture containing 500 ng of AP-1-luc or c-fos-luc promoter plasmids and 1 ng of pRL-cytomegalovirus. After 6 h, 500 ml of normal growth medium, and treatments were added to wells and then cells were incubated for an additional 18 h. Luciferase activity was measured using the Dual Luciferase Kit (Promega, Milan, Italy) according to the manufacturer's recommendations. Firefly luciferase values were normalized to the internal transfection control provided by the Renilla luciferase activity. The normalized relative light unit values obtained from cells treated with vehicle were set as onefold induction on which the activity induced by treatments was calculated.
Immunoblotting Cells were grown in 10-cm dishes, exposed to treatments and then lysed in 50 mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol, 1% Triton X-100, 0,1% odium dodecyl sulfate, and a mixture of protease inhibitors (Boeringher Ingelheim, Milan, Italy) . Equal amounts of whole protein extract were resolved on a 10% polyacrylamide gel electrophoresis, transferred to a nitrocellulose membrane (Amersham Biosciences, Arlington Heights, IL, USA), probed overnight at 4 1C with the antibodies against the indicated proteins and then revealed using the enhanced chemiluminescence system (Amersham Biosciences). For GPR30 silencing, cells were plated into 10-cm dishes, maintained in serum-free medium for 24 h, and then transiently transfected for an additional 24 h before treatments with 5 mg/plate short hairpin GPR30 or with the control empty vector. Transfections were performed using Fugene 6 reagent. For c-Fos overexpression, cells were plated into 10-cm dishes, maintained in normal growth medium and then transiently transfected in FBS 5% for 6 h before treatment with 10 mM OHT for additional 18 h. Transfections were performed using Fugene 6 reagent. GPR30 was revealed using the rabbit polyclonal antiserum LS-A4271 (MBLEppendorf, Milan, Italy). c-Jun, p-c-Jun Reverse transcription and real-time PCR Total RNA was extracted using the TRIzol commercial kit (Invitrogen, Milan, Italy) according to the manufacturer's protocol and reversed messenger RNA was quantified spectrophotometrically. Total complementary DNA was synthesized from the RNA by reverse transcription using the murine leukemia virus reverse transcriptase (Invitrogen) following the protocol provided by the manufacturer. The expression of cfos was quantified by real-time PCR using StepOne sequence detection system (Applied Biosystems Inc., Milan, Italy) following the manufacturer's instructions. Assays were performed in triplicate, and the mean values were used to calculate expression levels, using the relative standard curve method. Gene-specific primers were designed using Primer Express version 2.0 software (Applied Biosystems Inc.). For c-fos and the ribosomal protein 18S, which was used as a control gene to obtain normalized values, the primers were: 5 0 -C GAGCCCTTTGATGACTTCCT-3 0 (c-fos forward); 5 0 -GG AGCGGGCTGTCTCAGA-3 0 (c-fos reverse); 5 0 -GGCGTC CCCCAACTTCTTA-3 0 (18S forward) and 5 0 -GGGCATCA CAGACCTGTTAT-3 0 (18S reverse).
Immunofluorescence and TdT-mediated dUTP nick end labeling assays Cells were seeded in two-well Lab-Tek II chamber slides at a density of 1 Â 10 5 /well and incubated for 24 h in the corresponding maintenance media. Using Fugene 6 reagent as recommended by the manufacturer, cells were transiently transfected in FBS 5% for 6 h with an empty vector, the c-Fos, A-Fos and the HA-tagged c-Jun, c-Jun-PanAla (bearing alanine substitutions of all JNK sites) and c-Jun-Ala 91/93 (c-Jun mutant in T91/T93) expression vectors. Cells were then treated for 18 h with vehicle or 10 mM OHT.
For immunofluorescence staining, cultured SkBr3 cells were fixed in 4% paraformaldehyde, permeabilized with 0.1% TWEEN three times for 5 min, then were blocked for 1 h at room temperature with PBS containing 15% normal donkey serum (Santa Cruz Biotechnology, DBA, Milan, Italy), 0.1% Triton X-100 and 0.05% TWEEN. After incubations with a primary antibody against HA (HA-probe F-7 purchased from c-Jun mediates 4-hydroxytamoxifen-induced apoptosis A Madeo et al Santa Cruz Biotechnology, DBA, Milan, Italy) in PBS containing 15% normal donkey serum, 0.1% Triton X-100 and 0.05% TWEEN, slides were washed three times with PBS and incubated with the donkey secondary antibody against mouse IgG conjugated to rhodamine (1:300) (Santa Cruz Biotechnology, DBA).
For the detection of DNA fragmentation at the cellular level, cells were stained using DeadEnd Fluorometric TUNEL System (Promega) following the manufacturer's instructions. Nuclei of cells were stained with propidium iodide for the TUNEL assay or DAPI for immunofluorescent detection in combined TUNEL assay. Leica AF6000 Advanced Fluorescence Imaging System supported by quantification and image processing software Leica Application Suite Advanced Fluorescence (Leica Microsystems CMS, GbH Mannheim, Germany) were used for experiment evaluation.
Determination of caspase 3/7
Caspase 3/7 activation was determined using the Caspase-Glo 3/7 Assay (Promega) following the protocol provided by the manufacturer. Cells were plated in regular growth medium. Cancer cells were treated in FBS 5% with 10 mM OHT for 18 h and then incubated with Caspase-Glo 3/7 Reagent for 3 h. Thereafter, the caspase activity was determined by luminometer (Lumat LB 9507 Berthold, Pforzheim, Germany).
Dichlorofluorescein assay DCFH-DA was dissolved in dimethyl sulfoxide as stock solution and kept frozen in 20 1C. For loading the cells with DCFH, DCFH-DA from stock solution was mixed with loading medium (99% RPMI 1640 and 1% FBS) to a final concentration of 100 M. Adherent cells were collected by trypsin/ethylene-diaminetetraacetic acid, washed for two times in cold PBS and then incubated in 1-ml solution containing PBS and DCF for 30 min at 37 1C in the dark. After removing DCF by PBS wash, cells were incubated in 1 ml PBS solution, in ice, and then analysed by flow cytometry using a FacScan Flow Cytometer Apparatus (Dako). Acquisition and analysis was performed using SummitTM software. For each sample, 30 000 events were analysed.
Cell viability
For cell viability assay, cells were seeded (2 Â 10 4 ) in 24-well plates in normal growth medium supplemented with 10% FBS. Cells were washed extensively once then had attached and treated with 10 mM OHT for 18 h in the medium supplemented with 5% FBS. Then, cells were trypsinized and the numbers of Trypan blue excluding viable cells were counted in a haemocytometer (Strober, 2001) .
Statistical analysis
Statistical analysis was carried out using analysis of variance followed by Newman-Keuls' testing to determine differences in means. Po0.05 was considered as statistically significant.
